Non-alpha 2-adrenoceptor idazoxan binding sites; a new target for drug development.
Boots Pharmaceuticals, Nottingham, U.K.
A T
AT
Kilpatrick
C C
CC
Brown
A C
AC
Mackinnon
D000273:Adipose Tissue / Q000378:metabolism; D000317:Adrenergic alpha-Antagonists / Q000378:metabolism*; D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive; D004146:Dioxanes / Q000378:metabolism*; D015195:Drug Design; D006801:Humans; D019329:Idazoxan; D007700:Kinetics; D011942:Receptors, Adrenergic, alpha / Q000378:metabolism*; D011956:Receptors, Cell Surface / Q000378:metabolism*
D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D011942:Receptors, Adrenergic, alpha; D011956:Receptors, Cell Surface; D019329:Idazoxan